The strong projected growth and path to profitability are positive, but traders should verify if these are preliminary expectations by monitoring the next official 10-Q filing for actual Q1 2026 results and any updates to the full-year outlook.
Price Chart
Executive Summary
BIO-key previewed its 1H26 outlook, expecting 50% revenue growth to $5M and a shift to profitability, driven by a $1.04M software license renewal and over $1M in hardware contracts. This follows a challenging 2025 with a $4.6M net loss.
Key Financial Metrics
Key Facts
- Expects 1H26 2026 revenues to grow 50% to ~$5M vs. $3.3M in 1H25
- Expects positive net income in 1H26 vs. $1.9M net loss in 1H25
- Q126 revenue expected to grow 37% to $2.2M vs. $1.6M in Q125
- Q226 revenue expected to grow 65% to $2.8M vs. $1.7M in Q225
- Improved results driven by a $1.04M software license renewal and >$1M in hardware contracts
Financial Impact
Revenue growth of 50% and a swing to profitability in 1H26
Risk Factors
- Forward-looking statements are subject to risks and uncertainties, including the ability to convert sales opportunities to contracts and maintain working capital.
- The company has a history of losses and limited revenue, which poses a risk to achieving the projected profitability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-012772 |
| Exhibit: ex_946767.htm | 0001437749-26-012772 |
| Document: 0001437749-26-012772-index-headers.html | 0001437749-26-012772 |
| Document: 0001437749-26-012772-index.html | 0001437749-26-012772 |
| Document: 0001437749-26-012772.txt | 0001437749-26-012772 |
| 8-K Data (Synthetic) | 0001437749-26-012772 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | S-1 | $1.65 | awaiting T+60 | — | $3.39 (−105.45%) |
Oct 6, 2026 20d ago | DEFA14A | $1.76 | awaiting T+60 | — | $3.39 (+92.61%) |
Oct 6, 2026 20d ago | 8-K | $1.76 | awaiting T+60 | — | $3.39 (+92.61%) |
Oct 2, 2026 24d ago | 8-K | $1.93 | awaiting T+60 | — | $3.39 (−75.65%) |
Sep 29, 2026 27d ago | Press Release | $3.12 | awaiting T+60 | — | $3.39 (+8.65%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | — | $3.39 (−14.14%) |
Aug 14, 2026 10w ago | 8-K | $3.18 | awaiting T+60 | — | $3.39 (−6.60%) |
Aug 13, 2026 10w ago | Press Release | $3.18 | awaiting T+60 | — | $3.39 (+6.60%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | — | $3.39 (−18.71%) |
Jul 28, 2026 12w ago | Press Release | $4.25 $2.10 | ▼ −50.59% | ▼ −54.94% | $3.39 (−20.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers